The bioindustrial manufacturing nonprofit BioMADE has announced its flagship facility will be in Maple Grove, confirming ...

The company stated that it currently invests $1 billion annually in US-based R&D and plans to further expand its domestic footprint by creating jobs, increasing manufacturing and lab services capacity ...

Amgen on Friday announced a $900 million expansion of its Ohio biotech manufacturing facility, becoming the latest in a ...

YJ Biotechnology has been transforming regenerative medicine with its cost-efficient, internationally-certified and ...